Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Application of ctDNA in a Population at High-risk for Common Malignant Tumor

NCT04405557 is registered in ClinicalTrials.gov with Geneplus-Beijing Co. Ltd. as lead sponsor.

NCT NCT04405557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04405557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Application of ctDNA in a Population at High-risk for Common Malignant Tumor
Lead sponsor
Geneplus-Beijing Co. Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
November 12, 2019
Completion date
December 31, 2026
Enrollment
757 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

early detection of cancer